Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
A Phase 1/2, First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability,Pharmacokinetics, Biological and Clinical Activity of DF9001 as a monotherapy and in combination withnivolumab in Patients With Advanced (Unresectable, Re
- Beckwith, Heather C (PI)
Project: Research project